Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. J. Michael Cline

Market Cap

987.72 Million USD

Sector

Healthcare

Website

https://www.accolade.com

Description

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

Read More

Overview

Value

0

Growth

20

Health

56

Management

0

Analyst Opinion

71

Total

44

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Liked by analysts
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • 0
  • Disliked by Twitter users
  • Poor earnings and cashflow growth
  • 0

Market Peers

ACCD

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

N/A

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

Buy

Share Buybacks

N/A

Dividend Yeild (TTM)

N/A

Valuation

Value Score

0

  • Estimated intrinsic-value of N/A is lower than current price ( 13.57 USD)
  • Free-cashflow-yeild of -7.98% is worse than the market average (4.7%)
  • Margin-of-safety of N/A is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 13.4 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-7.98%

PE/Earnings Growth

N/A

Price/Book

2.00x

Growth

Growth Score

20

  • Revenue growth has improved this yeara
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

N/A

Earnings Growth

N/A

Cashflow Growth

N/A

Health

Health Score

56

  • Has a low level of debt
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Cashflow is negative
  • 0
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

5.00

Debt/Equity

0.37x

Current Assets/Liabilities

3.66x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

0.78x

Management

Management Score

0

  • Has not bought shares or issued new shares in the last 5 years
  • Return-on-capital-employed of -2.91% is lower than the market average (10%)
  • Return-on-equity of -16.41% is lower than the market average (15%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

14.04%

5 Year Price Volitility

38.74%

Return On Assets

-10.93%

Return On Capital Employed

-2.91%

Return On Equity

-16.41%

Return On Free Cashflow

N/A

Return On Investments

N/A

Social Sentiment

Social Sentiment Score

30

Twitter Sentiment

N/A

Stocktwits Sentiment

59.00

Analysts

Analyst Opinion

71

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Accolade, Inc.

Currency

USD

Beta

1.358294

Vol Avg

667377

Ceo

Mr. J. Michael Cline

Cik

0001481646

Cusip

00437E102

Exchange

NASDAQ Global Select

Full Time Employees

2350

Industry

Health Information Services

Sector

Healthcare

Ipo Date

2020-07-02

Address

660 West Germantown Pike

City

Plymouth Meeting

State

PA

Country

US

Zip

19462

Phone

206 926 8100

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies